Mdxhealth SA cash flow statement

In fiscal 2025, Mdxhealth SA's operations generated −$2.2m of cash; it spent $1.2m on capital projects, leaving free cash flow of −$3.3m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Mdxhealth SA: cash flow statement, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash from operations	−22	−20	−23	−34	−21	−19	−2
Depreciation and amortisation	2	2	1	3	4	5	5
Stock-based pay	1	1	1	1	1	2	2
Capital spending	0	1	1	3	3	1	1
Free cash flow	−22	−21	−23	−37	−24	−20	−3
Free cash flow after stock pay	−23	−22	−25	−38	−25	−21	−6

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BDSX vs MDXH HBIO vs MDXH CDXS vs MDXH

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Mdxhealth SA's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Mdxhealth SA.